Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study
- PMID: 32169303
- DOI: 10.1016/j.atherosclerosis.2020.02.020
Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study
Keywords: Cardiovascular disease; Dyslipidaemia guidelines; Epidemiology; Evidence; Primary prevention; Statin.
Conflict of interest statement
Declaration of competing interest The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.
Comment on
-
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31. Atherosclerosis. 2019. PMID: 31591002 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical